Physician profile
Russell Osnes
NPI 1982792867
$1,012.56
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $115 · 2021: $88.94 · 2022: $502.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $350.03 | 2019-2022 | |
| Coopervision INC. | $285.57 | 2019-2022 | |
| Alcon Research LLC | $150.44 | 2019 | |
| Glaukos Corporation | $115.04 | 2020 | |
| Integra Lifesciences Corporation | $34.88 | 2022 | |
| Alcon Vision LLC | $32.65 | 2019-2021 | |
| Tearlab Corp | $19.80 | 2022 | |
| Maculogix, INC. | $12.14 | 2019 | |
| Synergeyes, INC. | $12.01 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Osnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.